Chronic Kidney Disease

Older patients and those with chronic kidney disease who have abdominal aortic calcification are at elevated risk for future CV events and poorer prognosis, according to results published in the Journal of the American Heart Association.

Although higher systolic blood pressure at baseline was associated with eGFR decline in patients with chronic kidney disease, disease progression may be more accurately predicted when blood pressure is measured over time.

Swedish patients who had a stress-related disorder were more likely to experience chronic kidney disease progression and AKI compared with a population-matched control group.

Kidney disease is a public health crisis that costs the federal government more than $120 billion per year and threatens to bankrupt the Medicare Trust Fund.

For patients with non-valvular atrial fibrillation, study results showed treatment with apixaban was associated with a lower risk for chronic kidney disease progression compared with warfarin.

The FDA has granted priority review to Farxiga, from AstraZeneca, for the treatment of chronic kidney disease.

Approximately 10% to 17% of patients with type 2 diabetes and newly identified chronic kidney disease had their condition worsen within 2 years, according to a study published in the Clinical Kidney Journal.

Researchers from the Netherlands have identified benefits and risks associated with stopping renin-angiotensin system inhibitor therapy in patients with advanced chronic kidney disease.

Adding consideration of socioeconomic status to a standard screening approach for chronic kidney disease “modestly” increased rates of detection in terms of sensitivity, although this approach also resulted in decreased specificity.

A population-based study conducted in the Netherlands showed that individuals who had a first-degree relative or spouse with a history of chronic kidney disease were at greater risk for developing the condition.